Compare iShares Bitcoin Trust (IBIT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Bitcoin Trust vs Zimmer Biomet Holdings Inc — how do they compare? iShares Bitcoin Trust trades at $46.55 (market cap $67.31B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: iShares Bitcoin Trust is far larger — about 4× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while iShares Bitcoin Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Bitcoin Trust for 40 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| IBIT | ZBH | |
|---|---|---|
Market Cap | $67.31B | $16.95B |
Volume | 56,154,544 | 2,505,240 |
Sector | Crypto-linked | Health |
52-Week High | $66.20 | $103.98 |
52-Week Low | $33.29 | $79.58 |
Typical Hold Time | 40 Days | 89 Days |
Enterprise Value | — | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $46.26, down 2.01% today amid bearish technical signals. The stock faces resistance at $47-$48 with support at $44-$46. Recent news highlights significant institutional inflows, including a $196 million single-day inflow on October 1, 2026, reflecting renewed investor confidence despite current price weakness.
The outlook remains cautious with technical indicators showing bearish momentum, though strong institutional interest suggests potential recovery. Key risks include market volatility and ETF fee structures, while analyst sentiment appears mixed with ongoing monitoring of Bitcoin market dynamics influencing stock performance.
Zimmer Biomet (ZBH) trades at $88.91, up 0.47% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $2.07, beating estimates, and raised its 2026 outlook. Revenue growth remains steady, with 2025 revenue at $8.23B, though net income margin declined to 8.56%. The stock is supported by a quarterly dividend of $0.24 and a consensus price target of $103.11, suggesting potential upside.
The outlook is mixed: strong fundamentals and analyst optimism contrast with technical weakness. Investment opportunities include consistent earnings beats and dividend income, but risks involve rising debt levels and competitive pressures in the medical technology sector. The stock's current valuation at a P/E of 21.57 appears reasonable if growth continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
